Literature DB >> 26438062

Increased expression of C-C motif ligand 2 associates with poor prognosis in patients with gastric cancer after gastrectomy.

Hao Liu1, Zhenbin Shen1, Xuefei Wang1, Heng Zhang1, Jing Qin1, Xinyu Qin1, Jiejie Xu2, Yihong Sun3.   

Abstract

Previous studies have demonstrated the clinical significance of polarized tumor-associated macrophages (TAMs) in gastric cancer whereas the cytokines orchestrating TAM polarization remain elusive. This study aims to evaluate the prognostic value of C-C motif ligand 2 (CCL2) expression in gastric cancer patients after surgery. We examined CCL2 expression in tumor tissues by immunohistochemical staining in retrospectively enrolled 414 gastric cancer patients receiving gastrectomy at Zhongshan Hospital during 2008. We used Kaplan-Meier analysis and Cox regression models to assess the prognostic value of CCL2 expression. We generated a predictive nomogram from integrating CCL2 expression with the TNM staging system to evaluate 3- and 5-year overall survival. High intratumor CCL2 expression associated with adverse clinical outcome. Intratumor CCL2 expression provided additional prognostic value in gastric cancer patients. CCL2 expression, as well as well-established TNM staging parameters, was identified as independent prognostic factor for overall survival. The generated nomogram corresponded well with the ideal model in predicting the 3- and 5-year overall survival of gastric cancer patients. CCL2, an identified potential independent adverse prognosticator, could be integrated with TNM staging system to improve the predictive accuracy for overall survival in gastric cancer patients especially with advanced stages.

Entities:  

Keywords:  Biomarker; CCL2; Gastric cancer; Nomogram; Overall survival; Prognosis

Mesh:

Substances:

Year:  2015        PMID: 26438062     DOI: 10.1007/s13277-015-4092-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  31 in total

1.  Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment.

Authors:  Tsuyoshi Kuroda; Yasuhiko Kitadai; Shinji Tanaka; Xiaoqin Yang; Naofumi Mukaida; Masaharu Yoshihara; Kazuaki Chayama
Journal:  Clin Cancer Res       Date:  2005-11-01       Impact factor: 12.531

2.  Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells.

Authors:  Zvi G Fridlender; Veena Kapoor; George Buchlis; Guanjun Cheng; Jing Sun; Liang-Chuan S Wang; Sunil Singhal; Linda A Snyder; Steven M Albelda
Journal:  Am J Respir Cell Mol Biol       Date:  2010-04-15       Impact factor: 6.914

3.  Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resection.

Authors:  Heng Zhang; Xuefei Wang; Zhenbin Shen; Jiejie Xu; Jing Qin; Yihong Sun
Journal:  Gastric Cancer       Date:  2014-09-18       Impact factor: 7.370

4.  Identification of high affinity receptors for human monocyte chemoattractant protein-1 on human monocytes.

Authors:  T Yoshimura; E J Leonard
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

5.  X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.

Authors:  Robert L Camp; Marisa Dolled-Filhart; David L Rimm
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

6.  Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models.

Authors:  Massimo Zollo; Valeria Di Dato; Daniela Spano; Daniela De Martino; Lucia Liguori; Natascia Marino; Viviana Vastolo; Luigi Navas; Beatrice Garrone; Giorgina Mangano; Giuseppe Biondi; Angelo Guglielmotti
Journal:  Clin Exp Metastasis       Date:  2012-04-07       Impact factor: 5.150

7.  CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.

Authors:  Bin-Zhi Qian; Jiufeng Li; Hui Zhang; Takanori Kitamura; Jinghang Zhang; Liam R Campion; Elizabeth A Kaiser; Linda A Snyder; Jeffrey W Pollard
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

8.  Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes.

Authors:  B J Rollins; A Walz; M Baggiolini
Journal:  Blood       Date:  1991-08-15       Impact factor: 22.113

9.  High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma.

Authors:  Xiao-Dong Zhu; Ju-Bo Zhang; Peng-Yuan Zhuang; Hong-Guang Zhu; Wei Zhang; Yu-Quan Xiong; Wei-Zhong Wu; Lu Wang; Zhao-You Tang; Hui-Chuan Sun
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

Review 10.  Tumor-associated macrophages: from mechanisms to therapy.

Authors:  Roy Noy; Jeffrey W Pollard
Journal:  Immunity       Date:  2014-07-17       Impact factor: 31.745

View more
  4 in total

1.  Decreased expression of granulocyte-macrophage colony-stimulating factor is associated with adverse clinical outcome in patients with gastric cancer undergoing gastrectomy.

Authors:  Hao Liu; Chao Lin; Zhenbin Shen; Heng Zhang; Hongyong He; He Li; Jing Qin; Xinyu Qin; Jiejie Xu; Yihong Sun
Journal:  Oncol Lett       Date:  2017-08-09       Impact factor: 2.967

2.  CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer.

Authors:  Wenxia Xu; Qi Wei; Mengjiao Han; Bingluo Zhou; Hanying Wang; Jianbing Zhang; Qiang Wang; Jie Sun; Lifeng Feng; Shouyu Wang; Yang Ye; Xian Wang; Jianwei Zhou; Hongchuan Jin
Journal:  Int J Biol Sci       Date:  2018-06-03       Impact factor: 6.580

Review 3.  Is the C-C Motif Ligand 2-C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?

Authors:  Hiroaki Iwamoto; Kouji Izumi; Atsushi Mizokami
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923

4.  High expression of C-C chemokine receptor 2 associates with poor overall survival in gastric cancer patients after surgical resection.

Authors:  Ruochen Li; Heng Zhang; Hao Liu; Chao Lin; Yifan Cao; Weijuan Zhang; Zhenbin Shen; Jiejie Xu
Journal:  Oncotarget       Date:  2016-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.